scholarly journals Association of neck circumference and high blood pressure in children and adolescents: a case–control study

2015 ◽  
Vol 15 (1) ◽  
Author(s):  
Renata Kuciene ◽  
Virginija Dulskiene ◽  
Jurate Medzioniene
2016 ◽  
Vol 6 (3) ◽  
pp. 215
Author(s):  
Annibal Tagliaferri Sabino ◽  
Eduardo de Souza ◽  
Ana Lucia Goulart ◽  
Adriana Martins de Lima ◽  
Nelson Sass

Author(s):  
Camila Brandão-Souza ◽  
Claudia Souza Dourado ◽  
Gabriela Callo Quinte ◽  
Gláucia Figueiredo Justo ◽  
Maria Del Carmen Bisi Molina

Objetivo: Identificar e analisar os fatores preditores da ocorrência da pressão arterial elevada em crianças de 7 a 10 anos de um município rural no Espírito Santo. Métodos: Foram constituídos dois grupos de estudo: os casos (PAS ou PAD ≥ P95) e os controles (PA <P90). Houve pareamento por sexo e idade. A amostra foi composta por sorteio sistemático e foram avaliadas 395 crianças, 79 casos e 316 controles. Resultados: A prevalência de excesso de peso nos casos foi de 8,9% e nos controles de 11,1%, o sedentarismo esteve presente em 88,1% dos casos e em 87,9% dos controles e a média do tempo de tela foi de 97,7 minutos e 106,6 minutos por dia nos casos e controles respectivamente. Conclusão: Observou-se a necessidade da criação de políticas públicas que visam promoção da saúde para que os grupos vulneráveis recebam assistência desde a infância. Descritores: Criança, Pressão alta, Hipertensão.


Author(s):  
Luca Spiezia ◽  
Gianna Bogana ◽  
Elena Campello ◽  
Sara Maggiolo ◽  
Elena Pelizzaro ◽  
...  

AbstractPreeclampsia (PE) is a pregnancy complication characterized by high blood pressure and significant amounts of protein in the urine. Various coagulation abnormalities have been described in pregnant women with PE. The aim of the present case-control study was to evaluate whole blood thromboelastometry profiles, performed by ROTEMStandard ROTEMPreeclamptic women showed a significantly more rapid propagation phase in EXTEM assay than controls (CFT 62±15 vs. 75±15 s and α-angle 78±4 vs. 75±4°, p<0.01 in both cases). Moreover, MCF was significantly higher and ML significantly lower in women with PE than in healthy pregnant women (p=0.001 for all comparisons).ROTEM


2020 ◽  
Vol Volume 13 ◽  
pp. 425-430
Author(s):  
Mohammad Reza Namazi ◽  
Shekoofe Rouhani ◽  
Alireza Moarref ◽  
Mahsa Kiani ◽  
Seyed Sajjad Tabei ◽  
...  

Author(s):  
Annibal Sabino ◽  
Eduardo de Souza ◽  
Ana Goulart ◽  
Adriana Lima ◽  
Nelson Sass

Objective To evaluate whether the presence of maternal blood pressure reduces the risks of morbidity, perinatal mortality and morbidity at 24 months of age in very low birth weight infants (VLBWIs) compared with a control group. Methods A retrospective, observational, case-control study. Total 49 VLBWIs were allocated to the study group, called the maternal arterial hypertension group (AHG), and matched with 44 in the control group (CG). The infants were assessed during hospitalization and at 12 and 24 months corrected age at a specialized clinic. For the assessment of growth, the World Health Organization (WHO) Anthro software (Geneva, 2006) was used, and for the psychomotor assessment, the Denver II test was used. Results In relation to the antenatal variables, the infants of the AHG had more centralized circulation assessed by Doppler, received more corticosteroids and magnesium sulfate, and were born by cesarean section more frequently. In terms of the postnatal and in-hospital outcomes, the AHG had a higher gestational age at birth (30.7 versus 29.6 weeks) and a lower frequency of 5-minute Apgar scores of less than 7 (26.5% versus 52.3%). The CG had a higher rate of pulmonary dysplasia (30.2% versus 8.3%). There were no differences in terms of hospital mortality, complications, somatic growth and functional problems at 24 months of corrected age. Conclusion The presence of maternal hypertension, especially preeclampsia, was not a protective factor against morbidity, mortality and evolution in VLBWIs aged up to 24 months. Therefore, the clinical practice should be focused on prolonging the pregnancy for as long as possible in these conditions as well.


Author(s):  
Rajeev Gandham ◽  
CD Dayanand ◽  
SR Sheela

Introduction: Pre-eclampsia is a pregnancy specific disorder, characterised by the onset of hypertension and proteinuria. Pre-eclampsia is the leading cause of maternal, perinatal morbidity and mortality. The exact cause of pre-eclampsia is not known clearly and needs to be explored. Aim: To evaluate the maternal serum apelin 13 levels among pre-eclampsia and healthy pregnant women and also, to find the association between apelin 13 and blood pressure. Materials and Methods: A case-control study was conducted between Department of Biochemistry and Department of Obstetrics and Gynaecology, RL Jalappa Hospital and Research Centre, Kolar, Karnataka, India. After approval from the Institutional Ethics Committee and written informed consent from study subjects, a total of 270 pregnant women were recruited for this study. Among them, 135 pre-eclamptic women were considered as cases and 135 normotensive healthy pregnant women served as controls. According to the pre-eclampsia severity, cases were grouped into mild (n=47) and severe pre-eclampsia (n=88). Blood samples were collected from all the study subjects and was analysed for apelin 13 by Enzyme Linked Immunosorbent Assay (ELISA) method. Maternal and foetal adverse outcomes were recorded. Results were expressed as mean±Standard Deviation (SD). Categorical variables were expressed in percentages. Spearman’s correlation was applied and p<0.05 was considered significant. Results: The mean gestational age was 36.66±3.69 weeks which was, significantly low in pre-eclamptic women compared with healthy pregnant women. BMI (26.94±3.81 kg/m2), systolic (157.82±15.14 mmHg), diastolic (101.68±11.02 mmHg) and Mean Arterial Pressure (MAP) (120.20±11.12 mmHg), pulse rate (88.14±5.82 bpm), Aspartate Transaminase (AST) (25.25±12.49 IU/L) and Alanine Transaminase (ALT) (19.01±10.95 IU/L) were significantly increased in pre-eclamptic women when compared with control group. Mean maternal serum apelin 13 (341.44±218.63 pg/mL) concentrations were significantly lower in pre-eclampsia compared with healthy pregnant women. Maternal serum apelin 13 concentrations were negatively correlated with Systolic Blood Pressure (SBP) (r = -0.196), Diastolic Blood Pressure (DBP) (r = -0.172) and MAP (r =-0.204). Adverse maternal outcomes such as epigastric pain 75 (55.55%), oedema 62 (45.92%) and persistent headache 35 (25.92%) were higher in pre-eclamptic group. Additionally, adverse foetal outcomes were more in pre-eclamptic cases including significantly decreased birth weight (2.40±0.65), babies requiring Neonatal Intensive Care Unit (NICU) admission were 54 (40%), preterm birth (≤37 wks) in 50 (37.03%), Respiratory Distress Syndrome (RDS) 31 (22.96%), Small for Gestational Age (SGA) in 4 (2.96%) and Intra Uterine Death (IUD) in 11 (8.14%) babies. Conclusion: It was concluded from the present study that there was low maternal serum apelin 13 concentrations in pre-eclampsia and had negative correlation with blood pressure, suggesting its potential role in the pathophysiology of pre-eclampsia.


Sign in / Sign up

Export Citation Format

Share Document